XARACOLL is a Parenteral Implant in the Human Prescription Drug category. It is labeled and distributed by Innocoll Pharmaceuticals. The primary component is Bupivacaine.
| Product ID | 51715-100_23477215-fcfc-4b11-a5c3-b2034c31aefb | 
| NDC | 51715-100 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | XARACOLL | 
| Generic Name | Bupivacaine Hcl Collagen-matrix | 
| Dosage Form | Implant | 
| Route of Administration | PARENTERAL | 
| Marketing Start Date | 2020-08-28 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA209511 | 
| Labeler Name | INNOCOLL PHARMACEUTICALS | 
| Substance Name | BUPIVACAINE | 
| Active Ingredient Strength | 100 mg/1 | 
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 2020-08-28 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() XARACOLL  90738266  not registered Live/Pending  | 
        Innocoll Pharmaceuticals Limited  2021-05-27  | 
![]() XARACOLL  88806837  not registered Live/Pending  | 
        Innocoll Pharmaceuticals Limited  2020-02-22  | 
![]() XARACOLL  87724683  not registered Live/Pending  | 
        Innocoll Pharmaceuticals Limited  2017-12-18  | 
![]() XARACOLL  85080255  4092973 Dead/Cancelled  | 
        Innocoll Pharmaceuticals Limited  2010-07-08  |